Skip to main content

INVEGA TRINZA

NDC 50458-606 · Janssen Pharmaceuticals, Inc

Generic namepaliperidone palmitate
Dosage formINJECTION, SUSPENSION, EXTENDED RELEASE
RouteINTRAMUSCULAR
Active ingredient(s)PALIPERIDONE PALMITATE
Strength273 mg/.88mL
Pharmacologic classAtypical Antipsychotic [EPC]
Marketing categoryNDA

Packages

50458-606-01 — 1 SYRINGE in 1 KIT (50458-606-01) / 1 mL in 1 SYRINGE

Billed under HCPCS

J2427 — Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg Medicare Part B payment limit (ASP + 6%): $13.26

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50458-560 — paliperidone palmitate, 50458-561 — paliperidone palmitate, 50458-562 — paliperidone palmitate, 50458-563 — paliperidone palmitate, 50458-564 — paliperidone palmitate, 50458-607 — paliperidone palmitate, 50458-608 — paliperidone palmitate, 50458-609 — paliperidone palmitate, 50458-611 — paliperidone palmitate, 50458-612 — paliperidone palmitate, 72526-105 — paliperidone palmitate, 72526-106 — paliperidone palmitate, 72526-107 — paliperidone palmitate, 72526-108 — paliperidone palmitate, 72526-109 — paliperidone palmitate, 72526-110 — paliperidone palmitate